Categories News Press Releases Archives 2026 March February 2025 December November October September August July June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November September August June May March February January 2021 December November October September August May April February Nov 14 When Every Second Matters Read More Nov 04 Elevating the lives of people impacted by thymidine kinase 2 deficiency (TK2d) Read More Nov 03 U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d) Read More
